Headquartered in Dresden, Germany, with manufacturing in the Czech Republic, CMI extends Heraeus’ interventional device capabilities through its technology and competence in the design, development and integration of minimally-invasive medical device systems. More specifically, CMI possesses advanced capabilities in design specification for balloons, stents, and coiled or braided shaft technologies for sheaths and catheters.
CMI also adds to Heraeus’ existing interventional device production capacity and enhances support to partners seeking regulatory services for global device registration.
Martin Schachenmayr, managing director of CMI said, “Joining Heraeus enables us to better serve customers by combining our deep knowledge in advanced minimally-invasive devices with Heraeus’ global manufacturing scale. Both organizations have a shared passion for supporting customers in end-to-end product development and manufacturing, so we are eager to unlock our joint potential.”
Nicolas Guggenheim, president of Heraeus Medical Components added, “Our service offering is reflective of our customer’s needs to increasingly outsource development, production, and regulatory services. This acquisition, our fourth in just over two years, is part of an ongoing expansion of capabilities and competences within growing interventional device markets. CMI is a European leader in development services with top talent and capabilities that will complement our offering for the benefit of our customers.”